The Washington Academy of Biomedical Engineering Announces a Workshop

– – Free and Open to the Public – – No Reservation Required – –

INDIVIDUALIZED TREATMENT
USING PHARMACO-GENOMICS
& FUNCTIONAL IMAGING
 
The George Washington University
Marvin Center – 3rd Floor Amphitheater
21st and H streets, N.W., Washington, D.C.
Metro: Foggy Bottom/GWU
 
September 29, 2003
4:30 – 6:30 p.m. ~ Open Discussion and Reception to Follow

Michael R. Fannon, MBA

Vice-president and Chief Information Officer

Human Genome Sciences, Inc.

Donald Johann, M.D.

NCI – FDA Proteomics Program

FDA – NCI Clinical Proteomics Program Databank

Steven R. Patierno, Ph.D.

Professor of Pharmacology and Genetics, The George Washington University

Executive Director, The George Washington University Cancer Institute

The fields of pharmaco-genomics and functional imaging offer new opportunities for drug development and patient care.

Exploration is underway to examine the impact of individual genetic variations in response to drug treatment. This work is expected to improve understanding and treatment of such medical conditions as asthma, cancer, pain, and addictive behavior. Progress in methods of phenotyping and genotyping should aid diagnosis, and guide the drug of choice for an individual, as well as drug dosage, and regimen.

New imaging techniques permit early identification of tumor-cell changes and tumor microcirculation. This information can be expected to lead to better differentiation between “responders” and “non-responders” to chemotherapy, for patients with a range of cancer types.

In this workshop, experts in the field will identify prospects to transition these genetic-based pharmacologic and imaging methods from bench to bedside. Speakers will discuss the use of emerging technologies to identify genetic markers of persons with disease susceptibility, and the impact on large-scale clinical trials in the study individualized drug therapies. Discussion with the audience will follow the speakers’ presentations.